Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Myc and YAP roles in the control of the cell cycle [3T9 RNA-seq pharmacological treatment]

ABSTRACT: RNAseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts treated with Y27632 and Verteporfin

ORGANISM(S): Mus musculus

PROVIDER: GSE83868 | GEO | 2017/11/22

SECONDARY ACCESSION(S): PRJNA327280

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Myc and YAP roles in the control of the cell cycle [3T9 RNA-seq]

Project description:RNAseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts

2017-11-22 | GSE83867 | GEO

Myc and YAP roles in the control of the cell cycle [3T9 ChIP-seq]

Project description:ChIPseq analysis of YAP and Myc induced in quiescent and confluent 3T9 fibroblasts

2017-11-22 | GSE83866 | GEO

Impact of Verteporfin on HCC cells

Project description:Together with TEAD4 the Hippo pathway effector YAP stimulates chromosomal instability. Verteporfin is known to disrupt the physical YAP/TEAD interaction and tehrefore might prevent from chromosomal instability in liver cancer. Immortalized HCC cell line hepG2 is treated with Verteporfin for 24 hours.

2016-02-11 | E-GEOD-73396 | biostudies-arrayexpress

Myc and YAP roles in the control of the cell cycle [Liver ChIP-seq]

Project description:ChIPseq analysis was performed on liver of tet-YAP and tet-Myc transgenic mice induced for 2 days (R26-mice)

2017-11-22 | GSE83863 | GEO

Myc and YAP roles in the control of the cell cycle [Liver RNA-seq]

Project description:RNAseq analysis was performed on liver of tet-YAP and tet-Myc transgenic mice induced for 2 days (R26-mice) or 4 weeks (laptTA-mice) or in liver tumor noduli.

2017-11-22 | GSE83865 | GEO

Myc and YAP roles in the control of the cell cycle

Project description:Myc and YAP roles in the control of the cell cycle

| PRJNA327238 | ENA

Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

Project description:Expression profiling by RNA-seq

2017-12-01 | GSE107583 | GEO

Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

Project description:Myc and YAP roles in the control of the cell cycle [MEF RNA-seq pharmacological treatment]

| PRJNA420726 | ENA

YAP transcriptionally regulates ErbB2 to promote liver cell proliferation

Project description:The Hippo signaling pathway is implicated in regulation of liver size and dysregulation of this pathway contributes to tumorigenesis. The transcriptional targets and downstream pathways of the Hippo pathway effector YAP that contribute to liver growth have yet to be well-characterized. We examined the liver transcriptome in response to YAP overexpression and identify the ErbB signaling pathway as a mediator of cell growth downstream of YAP. ErbB2 is transcriptionally regulated by YAP in both the mouse liver and in HepG2 human hepatoma cells. Knockdown of YAP or pharmacological inhibition with verteporfin reduced ERBB2 levels in HepG2 cells. Analysis of ChIP-seq data revealed enrichment of the transcription factor TEAD4 at the ERBB2 promoter. Using luciferase reporter and chromatin immunoprecipitation assays, we show that YAP and TEAD directly bind to and activate a regulatory element in the ErbB2 promoter in both the mouse liver and HepG2 cells. Functionally, knockdown of YAP reduced EGF-induced ERBB2-mediated HepG2 cell proliferation and PI3K/AKT activation. Our findings highlight a mechanism by which YAP exerts its effects on liver cell proliferation through the ErbB signaling pathway by directly regulating the transcription of ErbB2.

2018-02-09 | GSE110383 | GEO

Pharmacological YAP activation promotes regenerative repair of cutaneous wounds.

Project description:Chronic cutaneous wounds remain a persistent unmet medical need that decrease expectancy and quality of life. Here, we report that topical application of PY-60, a small molecule activator of the transcriptional coactivator YAP, promotes regenerative repair of cutaneous wounds in pig and human models. Pharmacological YAP activation enacts a reversible pro-proliferative transcriptional program in keratinocytes and dermal cells that results in accelerated re-epithelization and regranulation of the wound bed. These results demonstrate that transient topical administration of a YAP activating agent may represent a generalizable therapeutic approach to treating chronic wounds.

2023-06-11 | GSE234332 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data